Lifevantage (NASDAQ: LFVN) reported Q2 EPS of $0.15, in-line with the analyst estimate of $0.15. Revenue for the quarter came in at $48.9 million versus the consensus estimate of $54.84 million.

GUIDANCE:

Lifevantage sees FY2026 EPS of $0.60-$0.80, versus the consensus of $1.05. Lifevantage sees FY2026 revenue of $185-200 million, versus the consensus of $227.5 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.